[Form 4] Accenture PLC Insider Trading Activity

Rhea-AI Filing Summary

Tempus AI, Inc. (symbol TEM) filed a Form 144 indicating that insider Ryan Fukushima intends to sell 20,000 common shares through Morgan Stanley Smith Barney on or about 07/07/2025. At the reference price used in the filing, the shares have an aggregate market value of $1.22 million. The proposed sale represents roughly 0.012 % of the company’s 168.1 million shares outstanding.

The stock was originally acquired as restricted-stock awards on 10/14/2015. The form also discloses that, within the past three months, the same insider (including 10b5-1 plan sales) has already disposed of 47,820 shares, generating gross proceeds of approximately $2.79 million across three transactions (20 k on 06/03/2025, 7.82 k on 05/20/2025, and 20 k on 05/06/2025).

The filing does not disclose any material non-public information and states the seller’s representation of compliance with Rule 10b5-1. While the dollar value is meaningful, the percentage of ownership being liquidated is small, suggesting limited direct impact on the share float. Nevertheless, continued insider selling can influence investor sentiment.

Positive

• Sale conducted under Rule 10b5-1, indicating a pre-arranged trading plan that reduces concerns about opportunistic timing.
• Only 0.012 % of shares outstanding are being sold, posing minimal dilution or liquidity risk.

Negative

• Continued insider selling trend—47,820 shares sold in prior three months, with another 20,000 planned—may signal reduced insider confidence.
• Aggregate insider proceeds exceed $4 million over a short period, potentially pressuring market sentiment.

Insights

Securities Analyst

TL;DR: Small (<0.02 %) insider sale adds to recent selling trend; sentiment negative but float impact immaterial.

The Form 144 shows another planned 20 k-share sale (~$1.22 M) by insider Ryan Fukushima after disposing of 47,820 shares since May. Cumulatively, the insider will have sold ~68 k shares, still under 0.05 % of shares outstanding, so dilution or liquidity effects are negligible. However, the pattern of sequential sales can weigh on market psychology, especially post-IPO companies where insider activity is closely watched. Presence of 10b5-1 designations mitigates allegations of opportunistic timing, but investors often interpret sustained insider selling as a lack-of-confidence signal. Overall impact: modestly negative for sentiment, not financially material.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharma Manish

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO-The Americas

3. Date of Earliest Transaction (Month/Day/Year)
07/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	07/05/2025		A		60(1)	A	$303.795	1,658	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Tempus AI (TEM) shares are proposed for sale under this Form 144?

20,000 common shares are scheduled for sale.

What is the approximate dollar value of the planned sale?

The filing lists an aggregate market value of $1,219,400.

When is the expected sale date for the shares?

The sale is expected on or about 07/07/2025.

How many shares has the insider sold in the last three months?

A total of 47,820 shares were sold between May 6 and June 3 2025.

What percentage of Tempus AI’s outstanding shares does the new sale represent?

Roughly 0.012 % of the 168,072,456 shares outstanding.

Is the transaction part of a Rule 10b5-1 trading plan?

Yes. Prior sales are flagged as 10b5-1, and the filer affirms compliance with Rule 10b5-1 in the notice.